MAT2A and neoplasm: In tumor-initiating cells, exogenous methionine is consumed at extreme rates, leading to pro-tumorigenic epigenetic modifications through methionine adenosyltransferase 2A (MAT2A), which metabolizes methionine to SAM to promote histone methylation[196].